Neuroprotective Research Potential Emerging studies indicate BPC-157 may: Support neuronal protection Influence brain-to-body signaling Assist recovery following neurological stress 5
Hypoglycemia: While semaglutide does not usually cause low blood sugar (hypoglycemia) on its own, individuals taking it along with other medications like insulin may be at risk
Their use for Alcohol Use Disorder (AUD) or drug addiction is considered "off-label." However, groundbreaking clinical research from 2025 and 2026 demonstrates that these medications significantly dampen the brain's reward centers, drastically curbing cravings for alcohol, opioids, and nicotine
Oztekin CV, Gur S, Abdulkadir NA, Lokman U, Akdemir AO, Cetinkaya M, et al
It helps preserve the lean tissue that keeps metabolism high and supports bone density, both of which are especially important during significant weight loss
Diverticulitis is not listed as a known adverse effect in the Summary of Product Characteristics (SmPC) for Wegovy, nor has it been identified as a safety signal in post-marketing surveillance by the MHRA or EMA